• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即时诊断检测和用于止血与血栓的新型临床前技术。

Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis.

机构信息

Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.

Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine, Georgia Institute of Technology, Atlanta, Georgia.

出版信息

Semin Thromb Hemost. 2021 Mar;47(2):120-128. doi: 10.1055/s-0041-1723798. Epub 2021 Feb 26.

DOI:10.1055/s-0041-1723798
PMID:33636744
Abstract

Hemostasis is a complex wound-healing process involving numerous mechanical and biochemical mechanisms and influenced by many factors including platelets, coagulation factors, and endothelial components. Slight alterations in these mechanisms can lead to either prothrombotic or bleeding consequences, and such hemostatic imbalances can lead to significant clinical consequences with resultant morbidity and mortality. An ideal hemostasis assay would not only address all the unique processes involved in clot formation and resolution but also take place under flow conditions to account for endothelial involvement. Global assays do exist; however, these assays are not flow based. Flow-based assays have been limited secondary to their large blood volume requirements and low throughput, limiting potential clinical applications. Microfluidic-based assays address the aforementioned limitations of both global and flow-based assays by utilizing standardized devices that require low blood volumes, offer reproducible analysis, and have functionality under a range of shear stresses and flow conditions. While still largely confined to the preclinical space, here we aim to discuss these novel technologies and potential clinical implications, particularly in comparison to the current, commercially available point-of-care assays.

摘要

止血是一个复杂的创面愈合过程,涉及许多机械和生化机制,并受到许多因素的影响,包括血小板、凝血因子和内皮细胞成分。这些机制的轻微改变可能导致血栓形成或出血后果,这种止血失衡可能导致严重的临床后果,从而导致发病率和死亡率。理想的止血测定法不仅要解决血栓形成和溶解过程中涉及的所有独特过程,还要在流动条件下进行,以考虑内皮细胞的参与。确实存在全球性的测定法;然而,这些测定法不是基于流动的。由于其对大量血液体积的需求和低通量,基于流动的测定法受到限制,限制了潜在的临床应用。微流控测定法通过利用需要少量血液体积、提供可重复分析且在一系列剪切应力和流动条件下具有功能的标准化设备来解决上述全球性和基于流动的测定法的局限性。尽管它们仍然主要局限于临床前领域,但在这里,我们旨在讨论这些新技术和潜在的临床意义,特别是与当前商业上可用的即时检验测定法相比。

相似文献

1
Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis.即时诊断检测和用于止血与血栓的新型临床前技术。
Semin Thromb Hemost. 2021 Mar;47(2):120-128. doi: 10.1055/s-0041-1723798. Epub 2021 Feb 26.
2
Application of microfluidic devices in studies of thrombosis and hemostasis.微流控装置在血栓形成与止血研究中的应用。
Platelets. 2017 Jul;28(5):434-440. doi: 10.1080/09537104.2017.1319047. Epub 2017 Jun 5.
3
Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices.用于评估血细胞损伤的微流控方法:聚焦于机械循环支持装置中的血栓形成风险。
Int J Artif Organs. 2016 Jun 15;39(4):184-93. doi: 10.5301/ijao.5000485. Epub 2016 Mar 30.
4
The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury.微流控技术在止血中的应用:临床诊断和血管损伤的仿生模型。
Curr Opin Hematol. 2013 Sep;20(5):417-23. doi: 10.1097/MOH.0b013e3283642186.
5
A microengineered vascularized bleeding model that integrates the principal components of hemostasis.一种整合了止血主要成分的微工程化血管化出血模型。
Nat Commun. 2018 Feb 6;9(1):509. doi: 10.1038/s41467-018-02990-x.
6
Hemostasis-on-a-chip / incorporating the endothelium in microfluidic models of bleeding.基于芯片的止血/将内皮细胞纳入出血的微流控模型中。
Platelets. 2023 Dec;34(1):2185453. doi: 10.1080/09537104.2023.2185453.
7
Hemostatic Testing in Critically Ill Infants and Children.危重症婴幼儿和儿童的止血检测
Front Pediatr. 2021 Jan 8;8:606643. doi: 10.3389/fped.2020.606643. eCollection 2020.
8
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time.用于实时研究全血与内皮相互作用及血凝块动力学的体外微流控疾病模型
J Vis Exp. 2020 May 24(159). doi: 10.3791/61068.
9
Recent advances in microfluidic platelet function assays: Moving microfluidics into clinical applications.微流控血小板功能检测的最新进展:将微流控技术应用于临床
Clin Hemorheol Microcirc. 2019;71(2):249-266. doi: 10.3233/CH-189416.
10
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time.一种用于血小板输注和止血的微流控流动腔模型可实时测量血小板沉积和纤维蛋白形成。
J Vis Exp. 2017 Feb 14(120):55351. doi: 10.3791/55351.

引用本文的文献

1
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis.血液凝固与超越:第四届马斯特里赫特血栓形成共识会议立场文件。
Thromb Haemost. 2023 Aug;123(8):808-839. doi: 10.1055/a-2052-9175. Epub 2023 Mar 13.
2
Association between Functional Parameters of Coagulation and Conventional Coagulation Tests in the Setting of Fluid Resuscitation with Balanced Crystalloid or Gelatine: A Secondary Analysis of an In Vivo Prospective Randomized Crossover Study.平衡晶体液或明胶进行液体复苏时凝血功能参数与传统凝血试验之间的关联:一项体内前瞻性随机交叉研究的二次分析
J Clin Med. 2022 Jul 14;11(14):4065. doi: 10.3390/jcm11144065.
3
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH.
血栓形成与止血的基础科学研究机会:国际血栓与止血学会科学标准委员会的交流。
J Thromb Haemost. 2022 Jun;20(6):1496-1506. doi: 10.1111/jth.15718. Epub 2022 Apr 22.